Can NPs Prescribe Adderall? State-by-State Rules (2026)

Yes. In most of the country a nurse practitioner can prescribe Adderall, and millions of prescriptions get written that way every year. A nurse practitioner who holds state prescriptive authority and a federal DEA registration can evaluate you, diagnose ADHD, and write the prescription without a physician ever seeing your chart.

But 20 states change that answer, and the pages that currently rank for this question get several of them wrong. Six bar it or allow it only in narrow cases. Oklahoma bars nurse practitioners from Schedule II drugs entirely, Arkansas lets a nurse practitioner refill your Adderall but not start it, Ohio allows it outside a short list of settings only for terminal patients, and Georgia rewrote its law in July 2024 while most published charts still show the old rule. Fourteen more allow it with strings attached, and two of those strings are short: most nurse practitioners in Kentucky can write only a 72-hour supply, and in Florida a 7-day supply. So the honest answer to "can a nurse practitioner prescribe Adderall" is yes in most of the country, and the details of these 20 states matter more than the headline. Our nurse practitioner prescriptive authority by state table covers all 51 jurisdictions.

Why Adderall Is Treated Differently From Other Prescriptions

Adderall is an amphetamine, and the DEA classifies it as a Schedule II controlled substance, the most tightly regulated category that can still be prescribed at all. That classification is federal and it applies in all 50 states. It's why there are no automatic refills on Adderall, why you often need a new prescription each month, and why pharmacies treat it differently from an antidepressant.

Two separate permissions have to line up before anyone can write for it. The first is federal: a DEA registration, which nurse practitioners apply for the same way physicians do. The second is your state's law on what an advanced practice nurse may prescribe. The federal layer is uniform. The state layer is not, and that's where the whole question actually lives.

Most states handle this simply. If a nurse practitioner has prescriptive authority and a DEA number, Schedule II is included, and ADHD stimulants come along with it. The 20 states in the table above don't. Six carve stimulants out by drug or by setting, and 14 attach a supply cap or a Schedule II condition such as a permit, a physician protocol or an experience threshold.

The Six States That Bar It or Nearly Do

Oklahoma is the only flat prohibition. The Board of Nursing keeps a document called the Exclusionary Formulary, which lists what an advanced practice nurse with prescriptive authority may not write for. It opens with "All Schedule I and II Controlled Dangerous Substances." There is no exception to work around and no setting where it flips. If you're seeing a nurse practitioner in Oklahoma for ADHD, your stimulant prescription has to come from a physician.

Arkansas draws the most useful distinction in the country, and it's one no other state makes explicitly. Under 17 CAR § 123-604, an advanced practice nurse can prescribe a Schedule II stimulant only if a physician started the prescription, that physician has seen you within the past six months, and the nurse practitioner is treating the same condition. In practice that means a nurse practitioner in Arkansas can keep your ADHD treatment going but cannot begin it. If you're newly diagnosed, your first prescription comes from a physician. If you've been on Adderall for years, your nurse practitioner can manage it, as long as a physician stays in the picture twice a year.

Texas restricts by setting rather than by drug. Texas Occupations Code § 157.0511 lets a physician delegate Schedule II prescribing only inside a hospital facility-based practice, for a patient admitted for 24 hours or more or being treated in the emergency department, or as part of hospice care for someone with a certified terminal illness. Routine outpatient ADHD care is neither of those. A nurse practitioner in a Texas psychiatry clinic cannot write for Adderall, even though the same nurse practitioner can write for Schedules III through V.

Ohio restricts by setting too, with a long list of exceptions. Ohio Rev. Code § 4723.481 lets a nurse practitioner prescribe a Schedule II drug only to a terminal patient, after a physician started it, for 72 hours, unless the prescription comes from one of fifteen listed settings. Hospitals, community mental health providers and federally qualified health centers are on the list, and so is an outpatient behavioral health practice where the nurse practitioner collaborates with a physician the practice employs. A psychiatric nurse practitioner in a practice that doesn't fit one of the fifteen cannot write for Adderall.

Missouri and Georgia both legislate by naming opioids, which has the side effect of leaving stimulants out. Missouri's § 334.104.2 RSMo lets a collaborative practice arrangement delegate Schedule II authority for hydrocodone-containing medications only, capped at a 120-hour supply, with a separate carve-out for hospice. Georgia's HB 557 took effect on July 1, 2024 and extended Schedule II authority to hydrocodone and oxycodone in emergencies, five days maximum, adults only, and only after the nurse has a year of experience plus a continuing education course. Neither list includes an amphetamine. So in both states a nurse practitioner gained real Schedule II authority without gaining any ability to treat ADHD with it.

Georgia is worth pausing on, because it shows how stale this topic's published information is. Nearly every chart and article ranking for this question today still describes Georgia as a state where nurse practitioners are limited to Schedules III through V. That stopped being true on July 1, 2024, and the Georgia Composite Medical Board published a summary of the change before it took effect. The law moved and the internet didn't.

The Fourteen States That Allow It With Limits

These are the states the five-state charts miss. In each of them a nurse practitioner can treat ADHD in an ordinary outpatient clinic, but the law attaches a cap or a condition that reaches stimulants. Two of the caps are short enough to change how care works.

Kentucky has the shortest cap we have verified. Under KRS 314.011(8)(a), a nurse practitioner's prescription for a Schedule II drug other than a hydrocodone combination product is "limited to a seventy-two (72) hour supply without any refill." That reaches Adderall, Vyvanse and Ritalin. The same subsection carves out some psychiatric nurse practitioners: psychostimulants "may be written for a thirty (30) day supply only by an advanced practice registered nurse certified in psychiatric-mental health nursing who is providing services in a health facility" licensed under KRS Chapter 216B, or in a regional mental health program under Chapter 210. Every Kentucky nurse practitioner who prescribes controlled substances also needs a separate collaborative agreement for them, called a CAPA-CS, under 201 KAR 20:057.

Florida caps it at seven days, unless a psychiatric nurse writes it. Fla. Stat. § 464.012(6)(a) requires the nurse practitioner formulary to "limit the prescribing of Schedule II controlled substances ... to a 7-day supply," then exempts "psychiatric medications prescribed by psychiatric nurses as defined in s. 394.455." The same paragraph reserves psychiatric controlled substances for patients under 18 to nurse practitioners who are also psychiatric nurses. The statute doesn't list which drugs count as psychiatric medications, so a Florida prescriber should confirm with the Board of Nursing how a given stimulant is treated, but for a child with ADHD the specialty is likely to decide who can write it.

South Carolina allows 30 days at a time, if the practice agreement names the drug. S.C. Code § 40-33-34(F)(1) lets a nurse practitioner prescribe "Schedule II nonnarcotic substances if listed in the practice agreement," provided "each such prescription must not exceed a thirty-day supply." ADHD stimulants are nonnarcotic Schedule II drugs, so the practical question is whether your nurse practitioner's agreement with their physician lists them. The much shorter five-day cap in the same statute covers narcotics only.

Illinois requires the physician to name the drug until the nurse practitioner earns full practice authority. Under 225 ILCS 65/65-40(d), a collaborating physician may delegate Schedule II authority, but the delegation "must identify the specific Schedule II controlled substances by either brand name or generic name," and each prescription is limited to a 30-day supply, with continuation only after the physician approves. A nurse practitioner with 4,000 clinical hours and 250 hours of continuing education after certification qualifies for full practice authority under 65/65-43, which covers Schedules II through V without that delegation.

Alabama and California run it through a physician's paperwork. In Alabama a nurse practitioner needs a Limited Purpose Schedule II Permit, and Ala. Admin. Code r. 540-X-20-.07 requires "a specific practice formulary listing the specific Schedule II controlled substances" the board approves, limited to drugs customarily used in the collaborating physician's specialty. In California, Bus. & Prof. Code § 2836.1(f) requires Schedule II drugs to be furnished "in accordance with a patient-specific protocol approved by the treating or supervising physician." California also has a newer route under § 2837.103, which lets a nurse practitioner with three years or 4,600 hours of transition practice prescribe without standardized procedures in the settings that section names.

Eight more attach a cap or condition of their own. Pennsylvania limits each Schedule II prescription to 30 days, as identified in the collaborative agreement. Michigan allows Schedule II only as a delegated act of a physician. Nevada requires 2 years or 2,000 hours of clinical experience, or a physician's protocol. Connecticut, North Carolina and Virginia let the physician agreement set which controlled substances a nurse practitioner may write, Louisiana approves controlled-substance privileges one nurse practitioner at a time, and Wisconsin limits Schedule II amphetamines to listed uses, with ADHD on the list. Our prescriptive authority table quotes each state's rule.

Why West Virginia Keeps Showing Up on These Lists Incorrectly

Search this question and you'll find West Virginia named as a state that restricts nurse practitioner Schedule II prescribing. That reputation comes from a real provision, but it does not apply to Adderall.

W. Va. Code § 30-7-15a says an advanced practice registered nurse "may prescribe up to a three-day supply of a Schedule II narcotic." The operative word is narcotic. Adderall is an amphetamine, a stimulant, not a narcotic, and the statute goes on to say there are no other limitations on an advanced practice nurse's prescribing beyond that cap and the Schedule I bar. The three-day limit is an opioid rule that got summarized into a Schedule II rule somewhere along the way, and the summary has been copied ever since.

This is the practical reason we track stimulants separately from Schedule II as a whole. A chart that collapses West Virginia, Missouri and Oklahoma into one "restricted" column tells a West Virginian with ADHD the opposite of what the code says.

Does a Psychiatric Nurse Practitioner Have More Authority?

Usually not, but in three states it does. A PMHNP is the nurse practitioner specialty trained specifically in mental health, so you'd reasonably expect broader prescribing authority for psychiatric medication. Most prescribing laws don't work that way. They treat advanced practice nurses as a category, regardless of population focus, so a psychiatric nurse practitioner in Oklahoma has exactly the same Schedule II authority as a family nurse practitioner in Oklahoma, which is none. The same holds in Texas, Missouri, Georgia, Arkansas and Ohio.

Kentucky and Florida are the two exceptions that widen what a psychiatric nurse practitioner can write. In Kentucky, only a nurse practitioner certified in psychiatric-mental health nursing and working in a licensed health facility or a regional mental health program can write a stimulant for 30 days instead of 72 hours. In Florida, the seven-day cap doesn't apply to psychiatric medications prescribed by psychiatric nurses, and for patients under 18 the law reserves psychiatric controlled substances to nurse practitioners who are psychiatric nurses. In both states the specialty can be the difference between a normal stimulant prescription and one that has to be rewritten every few days. Rhode Island goes the other way: APRNs with a psychiatric/mental health focus get Schedule II stimulants but not other Schedule II drugs, so stimulants stay covered while opioids drop out.

Everywhere else, the specialty matters for everything other than legal authority. A PMHNP has done graduate coursework in psychopharmacology and supervised clinical hours in psychiatric settings, so where no stimulant carve-out applies, a psychiatric nurse practitioner is often the clinician most comfortable diagnosing and managing ADHD. If you want the broader picture of what the role can prescribe, our guide on whether a PMHNP can prescribe medication covers the full range, and our state requirements lookup shows the practice-authority rules for all 50 states and DC.

One thing worth separating: practice authority and drug schedules are different questions. A state can require a nurse practitioner to work under a collaborative agreement while placing no special limit on stimulants, and a state can grant broad independence while still carving out Schedule II. California is restrictive on practice authority and has no stimulant-specific rule, only a protocol requirement that covers all of Schedule II. Arkansas requires collaboration and singles stimulants out by name. Reading one off the other is how bad charts get made.

Can a Nurse Practitioner Diagnose ADHD?

Yes, in every state. Diagnosis and prescribing are governed separately, and every provision quoted above regulates prescribing, not diagnosis. A nurse practitioner can take your history, screen you with standardized rating scales, rule out the conditions that mimic ADHD, and put the diagnosis in your chart on their own assessment.

That's why the Arkansas rule is less disruptive than it sounds. A nurse practitioner there can do the entire diagnostic workup. What they cannot do is write the first stimulant prescription that follows from it. And in Oklahoma, Texas, Missouri and Georgia, a nurse practitioner can diagnose you with ADHD and then has to hand the prescription to a physician, which is an awkward split that many clinics manage with a standing referral arrangement.

What About Getting Adderall Through Telehealth?

Telehealth adds a federal layer on top of everything above. Prescribing a controlled substance to a patient a clinician has only ever seen on video is governed by the Ryan Haight Act and the DEA's telemedicine rules, which have been extended and revised repeatedly since 2020 rather than settled. Check the current status before you count on it, because this is the one part of the answer with a real chance of having changed since this was written.

Two things stay true regardless of where the federal rules land. State law still applies, so a telehealth nurse practitioner cannot prescribe Adderall into Oklahoma no matter where the clinician sits. And the clinician has to be licensed in the state where you are physically located, not where the company is based, which is why telepsychiatry nurse practitioners often carry licenses in five or ten states. If that side of the field interests you, our telehealth PMHNP salary guide covers what the work pays.

Does This Apply to Vyvanse and Ritalin Too?

Yes. The restrictions above are written against the schedule, not the brand, and the common ADHD stimulants all sit in Schedule II: Adderall and its generic amphetamine salts, Vyvanse (lisdexamfetamine), Ritalin and Concerta (methylphenidate), and Dexedrine. Swapping one stimulant for another does not get around a state rule, because the law never mentioned Adderall in the first place.

What does change the picture is the non-stimulant side of ADHD treatment. Atomoxetine (Strattera), viloxazine (Qelbree), guanfacine (Intuniv) and clonidine are not controlled substances at all, so none of the Schedule II rules touch them. A nurse practitioner in Oklahoma who cannot write for Adderall can prescribe any of these. They work differently from stimulants, they take weeks rather than hours to show an effect, and they don't suit everyone. But they're a genuine treatment path rather than a consolation prize, and in a restricted state they're often how a nurse practitioner manages ADHD without a physician handoff.

What to Do If You're in One of These States

If you're a patient, the workaround is usually administrative rather than clinical. Most psychiatry practices in restricted states already run on a shared model where a nurse practitioner handles your visits and a physician signs the stimulant prescription. Ask the practice directly how they handle Schedule II before you book, because finding out at the end of a 50-minute intake is the bad version of this. In Arkansas specifically, ask whether they can take you on as a transfer if you already have a prescription, since that's the case the rule is built to allow. In Kentucky and Florida, ask how the practice handles the supply cap, and whether your prescriber is a psychiatric nurse practitioner the cap doesn't bind.

If you're a nurse practitioner deciding where to practice, this belongs on the list with salary and cost of living. Not being able to prescribe the primary treatment for one of the most common conditions you'll see is a real constraint on the job, and it's one that rarely comes up in an interview. Our PMHNP programs by state directory lays out where each state stands on licensure, and the AANP state practice environment map tracks practice authority nationally.

One last caution. This area moves. Georgia changed in 2024, and several states have active bills on nurse practitioner prescribing in any given session. Everything above was checked word for word against the primary statute, rule or board document, most recently on October 8, 2026, and the sources are listed below so you can check them yourself. If you're making a decision that depends on this, confirm with your state board of nursing, which is the only body whose answer is binding.